Hyundai Bioscience

048410.KQ

9.47 USD

-0.16

-1.66%

Overview

Last close

9.47 usd

Market cap

400.10M usd

52 week high

29.00 usd

52 week low

9.15 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

62.7069

Price/Book Value

13.2463

Enterprise Value

413.06M usd

EV/Revenue

37.7219

EV/EBITDA

-64.6317

Key financials

Revenue TTM

6.40M usd

Gross Profit TTM

2.35M usd

EBITDA TTM

-5.05M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

105.70B usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.